A carregar...
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy
The decrement in plasma glucose concentration with SGLT2 inhibitors (SGLT2i) is blunted by a rise in endogenous glucose production (EGP). We investigated the ability of incretin treatment to offset the EGP increase. Subjects with type 2 diabetes (n = 36) were randomized to 1) canagliflozin (CANA), 2...
Na minha lista:
| Publicado no: | Diabetes |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7301339/ https://ncbi.nlm.nih.gov/pubmed/29602791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-1278 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|